Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.

Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.

<h4>Background</h4>The Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of <120 mm Hg compared with a SBP goal of <140 mm Hg. Our study aimed to assess the appl...

Full description

Bibliographic Details
Main Authors: Chao Li, Kangyu Chen, Victoria Cornelius, Ewan Tomeny, Yang Wang, Xiaowei Yang, Xiaodan Yuan, Rui Qin, Dahai Yu, Zhenqiang Wu, Duolao Wang, Tao Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-03-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003515

Internet

https://doi.org/10.1371/journal.pmed.1003515

Similar Items